- Report
- January 2019
- 348 Pages
Global
From €4183EUR$4,400USD£3,514GBP
- Report
- October 2024
Global
From €3327EUR$3,500USD£2,795GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1378EUR$1,450USD£1,158GBP
- Report
- March 2022
Japan, United States, ... Japan, United States, Europe
From €1378EUR$1,450USD£1,158GBP
The Benzodiazepine Test is a drug abuse screening test used to detect the presence of benzodiazepines in a person's system. Benzodiazepines are a class of drugs commonly prescribed to treat anxiety, insomnia, and seizures. They are also commonly abused and can lead to addiction and overdose. The Benzodiazepine Test is used to detect the presence of benzodiazepines in a person's system, allowing medical professionals to identify potential abuse and take appropriate action.
The Benzodiazepine Test market is composed of companies that provide testing services and products to detect benzodiazepines in a person's system. These companies offer a variety of testing methods, including urine, saliva, and blood tests. They also provide products such as test kits, reagents, and consumables. Companies in the Benzodiazepine Test market include Siemens Healthineers, Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, and Alere. Show Less Read more